However, appetite suppression can increase the risk of falling, age-related muscle and bone density loss, hypoglycemia misdiagnosis, and nutrient deficiencies
Tirzepatide as monotherapy improved markers of beta-cell function and insulin sensitivity in type 2 diabetes (SURPASS-1)
Preventing Diabetic Neuropathies Diabetic neuropathy encompasses various nerve disorders affecting peripheral, autonomic, and spinal nerves
Potential Risks Sub-therapeutic dosing may delay A1C control for diabetic patients
Letting a trusted friend, partner, or colleague know that you are on medication that causes temporary digestive effects can reduce the anxiety and embarrassment significantly
Why GLP-1 Medications Can Make Symptoms Worse GLP-1 medications can amplify these issues in a few ways: Changes in appetite and eating patterns Increased sensitivity to fullness and pressure Altered breathing patterns due to discomfort Increased abdominal guarding or bracing When breathing mechanics shift and the diaphragm is not moving well, pressure is often redirected outward into the abdomen instead of being managed efficiently within the system
